SCHEMBL6879853

SCHEMBL6879853

CN(C)c1ccnc(N[C@H]2CC[C@@H](NC(=O)Cc3ccc(Cl)cc3)CC2)n1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.57
MCHR1 Q99705 9/20 0.53
ADRA2A P08913 3/20 0.53
HRH1 P35367 3/20 0.53
HTR2B P41595 3/20 0.53
ADRA1A P35348 1/20 0.53
POLB P06746 1/20 0.51
AURKA O14965 1/20 0.51
AURKB Q96GD4 1/20 0.51
SIGMAR1 Q99720 1/20 0.44
GRM7 Q14831 1/20 0.44
ATF4 P18848 1/20 0.42
ACHE P22303 1/20 0.42
BACE1 P56817 1/20 0.42
IKBKB O14920 3/20 0.41
CDC7 O00311 1/20 0.40
DAPK3 O43293 1/20 0.40
ROCK2 O75116 1/20 0.40
MAP4K4 O95819 1/20 0.40
PAK4 O96013 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6879858 1.00 LMNA (0.57) LMNAMCHR1ADRA2AHRH1HTR2B
SCHEMBL6876747 0.89 MCHR1 (0.53) LMNAMCHR1ADRA2AHRH1HTR2B
SCHEMBL6876753 0.89 MCHR1 (0.53) LMNAMCHR1ADRA2AHRH1HTR2B
SCHEMBL6874044 0.89 AURKA (0.50) MCHR1ADRA2AHRH1HTR2BADRA1A
SCHEMBL6874037 0.89 AURKA (0.50) MCHR1ADRA2AHRH1HTR2BADRA1A
SCHEMBL6456315 0.89 MCHR1 (0.50) LMNAMCHR1ADRA2AHRH1HTR2B
SCHEMBL6456307 0.89 MCHR1 (0.50) LMNAMCHR1ADRA2AHRH1HTR2B
SCHEMBL6875733 0.89 MCHR1 (0.53) LMNAMCHR1ADRA2AHRH1HTR2B
SCHEMBL6875739 0.89 MCHR1 (0.53) LMNAMCHR1ADRA2AHRH1HTR2B
SCHEMBL6869412 0.88 EPHX2 (0.55) MCHR1POLBAURKAAURKBSIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1464335-A2 Quinoline, tetrahydroquinoline and pyrimidine derivatives as mch antagonist Taisho Pharmaceutical Co. Ltd. (JP) 2004-10-06 EP disclosed